Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

1281 results about "Patient Base" patented technology

The total number of patients that have been evaluated or treated.

Systems and methods for processing sensor data

Systems and methods for processing sensor data are provided. In some embodiments, systems and methods are provided for calibration of a continuous analyte sensor. In some embodiments, systems and methods are provided for classification of a level of noise on a sensor signal. In some embodiments, systems and methods are provided for determining a rate of change for analyte concentration based on a continuous sensor signal. In some embodiments, systems and methods for alerting or alarming a patient based on prediction of glucose concentration are provided.
Owner:DEXCOM

Methods and systems for predicting cancer outcome

The invention provides a molecular marker set that can be used for prognosis of colorectal cancer in a colorectal cancer patient. The invention also provides methods and computer systems for evaluating prognosis of colorectal cancer in a colorectal cancer patient based on the molecular marker set. The invention also provides methods and computer systems for determining chemotherapy for a colorectal cancer patient and for enrolling patients in clinical trials.
Owner:H LEE MOFFITT CANCER CENT & RES INST INC +1

Apparatus to deliver oxygen to a patient

InactiveUS20060042631A1Restricting trainingBreathing filtersDrug and medicationsHigh rateOxygen delivery
Disclosed is an oxygen delivery device for regulating the flow of oxygen from an oxygen source to a respiratory cannula located on the face of a patient. A host controller coupled to the oxygen delivery device accepts an input from a medical monitor relating to the blood oxygen saturation percentage of the patient. The host controller then regulates the rate of oxygen supplied to the patient based in part upon the blood oxygen saturation percentage of the patient. A high rate of oxygen is supplied to the patient when the controller detects a blood oxygen saturation level below a predetermined percentage and a low rate of oxygen is supplied when the controller detects a blood oxygen saturation level above a predetermined percentage in an order to minimize wasted oxygen.
Owner:ETHICON ENDO SURGERY INC

Implantable Medical Device with Chemical Sensor and Related Methods

In an embodiment, the invention includes an implantable medical device with a pulse generator and a chemical sensor in communication with the pulse generator, the chemical sensor configured to detect an ion concentration in a bodily fluid. In an embodiment, the invention includes a method for providing cardiac arrhythmia therapy to a patient including sensing a physiological concentration of an analyte, communicating data regarding the physiological concentration of the analyte to an implanted pulse generator, and delivering therapy to the patient based in part on the physiological concentration of the ion. In an embodiment, the invention includes a method for monitoring diuretic therapy. In an embodiment, the invention includes a method for controlling delivery of an active agent into a human body. Other aspects and embodiments are provided herein.
Owner:CARDIAC PACEMAKERS INC

Adjusting acquisition protocols for dynamic medical imaging using dynamic models

ActiveUS20100183206A1More standardizedBetter quantifiableImage enhancementImage analysisDynamic modelsHemodynamics
The invention relates to automatically adjusting an acquisition protocol for dynamic medical imaging, such as dynamic CT, MRI or PET imaging. The protocols are adjusted based on anatomic and dynamic models (10, 12, 14) which are individualized or fitted to each patient based on a scout scan (6, 8). The adjustment can compensate for changes in the patient due to patient motion (e.g. breathing or heartbeat) or flow of contrast or tracing agent during the sequence. This ensures that changes in the reconstructed images are indicative of pathological changes in the patient and not caused by patient motion or changes in scanning parameters or timing. The dynamic model can be a motion model (12) used to predict the motion of anatomic / physiologic features, typically organs, during scanning, or a haemodynamic model (14) used to predict flow of the contrast agent allowing for precise timing of the scanning sequence.
Owner:KONINKLIJKE PHILIPS ELECTRONICS NV

Early warning method and system for chronic disease management

InactiveUS20110184250A1Avoid and mitigate predicted health exacerbationAvoid or mitigate the predicted health exacerbationsMedical simulationHealth-index calculationControl setNetwork on
A computer-implemented method and system are provided for assisting a plurality of patients manage chronic health conditions. The method, for each patient, comprises: (a) receiving information from the patient or a member of a patient care network on an expected patient activity at a given future time period; (b) determining expected transient local ambient conditions in the patient's surroundings during the expected patient activity at the given future time period; (c) predicting health exacerbations for the patient using a stored computer model of the patient based on a desired patient control set-point range, the expected patient activity, and the expected transient local ambient conditions; and (d) proactively sending a message to the patient or a member of the patient care network before the given future time period, the message alerting the patient or a member of the patient care network of the predicted health exacerbations for the patient and identifying one or more corrective actions for the patient to avoid or mitigate the predicted health exacerbations.
Owner:QUVIUM
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products